MXPA03009728A - Solucion oral de aripiprazol. - Google Patents

Solucion oral de aripiprazol.

Info

Publication number
MXPA03009728A
MXPA03009728A MXPA03009728A MXPA03009728A MXPA03009728A MX PA03009728 A MXPA03009728 A MX PA03009728A MX PA03009728 A MXPA03009728 A MX PA03009728A MX PA03009728 A MXPA03009728 A MX PA03009728A MX PA03009728 A MXPA03009728 A MX PA03009728A
Authority
MX
Mexico
Prior art keywords
oral solution
aripiprazole oral
aripiprazole
solution
oral
Prior art date
Application number
MXPA03009728A
Other languages
English (en)
Inventor
Joyce Chou
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23099862&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03009728(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MXPA03009728A publication Critical patent/MXPA03009728A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
MXPA03009728A 2001-04-25 2002-04-24 Solucion oral de aripiprazol. MXPA03009728A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28671801P 2001-04-25 2001-04-25
PCT/US2002/013048 WO2002085366A1 (en) 2001-04-25 2002-04-24 Aripiprazole oral solution

Publications (1)

Publication Number Publication Date
MXPA03009728A true MXPA03009728A (es) 2004-01-29

Family

ID=23099862

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009728A MXPA03009728A (es) 2001-04-25 2002-04-24 Solucion oral de aripiprazol.

Country Status (37)

Country Link
US (1) US6977257B2 (es)
EP (2) EP2436384B2 (es)
JP (1) JP4401077B2 (es)
KR (1) KR100909329B1 (es)
CN (1) CN1512884B (es)
AR (1) AR033168A1 (es)
AT (1) ATE537831T1 (es)
AU (1) AU2002254722B2 (es)
BG (1) BG66177B1 (es)
BR (1) BR0208986A (es)
CA (1) CA2445276C (es)
CY (1) CY1112606T1 (es)
CZ (1) CZ306181B6 (es)
DK (1) DK1381367T3 (es)
EE (1) EE05581B1 (es)
ES (1) ES2377855T3 (es)
GE (1) GEP20053602B (es)
HK (2) HK1058316A1 (es)
HR (1) HRP20030870B1 (es)
HU (1) HU230456B1 (es)
IL (2) IL158202A0 (es)
IS (1) IS2863B (es)
MX (1) MXPA03009728A (es)
MY (1) MY129350A (es)
NO (1) NO324606B1 (es)
NZ (1) NZ528550A (es)
PE (1) PE20021086A1 (es)
PL (1) PL206882B1 (es)
PT (1) PT1381367E (es)
RS (1) RS52082B (es)
RU (1) RU2295960C2 (es)
SK (1) SK287948B6 (es)
TW (1) TWI337865B (es)
UA (1) UA76144C2 (es)
UY (1) UY27273A1 (es)
WO (1) WO2002085366A1 (es)
ZA (1) ZA200307797B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770478B2 (en) * 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
SI1542668T1 (sl) * 2002-08-20 2009-08-31 Bristol Myers Squibb Co Aripiprazol sestavljena formulacija in postopek
ES2373042T3 (es) * 2003-10-08 2012-01-30 Mallinckrodt Llc Solución de metilfenidato y procedimientos de administración y producción asociados.
AU2004285448C1 (en) * 2003-10-23 2021-08-19 Otsuka Pharmaceutical Co., Ltd. Controlled release sterile injectable aripiprazole formulation and method
JP4994043B2 (ja) * 2004-01-21 2012-08-08 エランコ・アニマル・ヘルス・アイルランド・リミテッド ミトラタピデ経口用溶液
CA2622758A1 (en) 2005-09-15 2007-03-29 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
ATE429906T1 (de) * 2006-01-05 2009-05-15 Teva Pharma Trockene aripiprazolformulierungen
US8865722B2 (en) * 2006-01-05 2014-10-21 Teva Pharmaceutical Industries Ltd. Wet formulations of aripiprazole
JP4892264B2 (ja) * 2006-03-30 2012-03-07 高田製薬株式会社 リスペリドン水性液剤
WO2007144874A1 (en) * 2006-06-12 2007-12-21 Hadasit Medical Research Services And Development Ltd. Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication
GB0618879D0 (en) 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
CN101801342B (zh) 2007-07-31 2012-07-11 大塚制药株式会社 制造阿立哌唑悬浮液和冻干制剂的方法
WO2009042166A1 (en) * 2007-09-25 2009-04-02 Panacos Pharmaceuticals, Inc. Liquid bevirimat dosage forms for oral administration
GB2456183A (en) * 2008-01-04 2009-07-08 Gw Pharma Ltd Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
AU2009329867B2 (en) 2008-12-23 2015-01-29 Gilead Pharmasset Llc Nucleoside phosphoramidates
NZ617066A (en) 2008-12-23 2015-02-27 Gilead Pharmasset Llc Nucleoside analogs
EA019295B1 (ru) 2008-12-23 2014-02-28 Джилид Фармассет, Ллс. Соединения пуриновых нуклеозидов и способ их получения
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8815261B2 (en) * 2009-06-19 2014-08-26 Medrx Co., Ltd. Composition for external application comprising aripiprazole and organic acid as active ingredients
TR201000948A1 (tr) 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazol formülasyonları.
AU2011235044A1 (en) 2010-03-31 2012-11-22 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
EP2552933A1 (en) 2010-03-31 2013-02-06 Gilead Pharmasset LLC Purine nucleoside phosphoramidate
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
WO2012075140A1 (en) 2010-11-30 2012-06-07 Pharmasset, Inc. Compounds
SI2685979T1 (sl) 2011-03-18 2017-04-26 Alkermes Pharma Ireland Limited Injekcijski farmacevtski sestavki, ki obsegajo vodotopni antipsihotik, sorbitan lavrat in polisorbat 20
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
JP6034377B2 (ja) * 2011-06-27 2016-11-30 シャンハイ チョンシ ファーマシューティカル コーポレイション アリピプラゾール医薬製剤及びその調製方法
CN102846616B (zh) * 2011-06-27 2015-05-06 上海中西制药有限公司 一种阿立哌唑制剂及其制备方法
JO3190B1 (ar) * 2011-10-19 2018-03-08 Otsuka Pharma Co Ltd محلول للتناول عن طريق الفم
CA2867137C (en) 2012-03-19 2020-12-08 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol
JP6219918B2 (ja) 2012-03-19 2017-10-25 アルカームス ファーマ アイルランド リミテッド グリセロールエステルを含む医薬組成物
NZ630643A (en) 2012-03-19 2017-08-25 Alkermes Pharma Ireland Ltd Pharmaceutical compositions comprising fatty acid esters
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
EP2868319A4 (en) * 2012-06-29 2016-02-24 Maruishi Pharma ORAL PHARMACEUTICAL PREPARATION OF ARIPIPRAZOLE
JP5341282B1 (ja) * 2012-06-29 2013-11-13 丸石製薬株式会社 アリピプラゾールの経口医薬製剤
KR101571670B1 (ko) 2012-08-08 2015-11-25 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제
JP6654042B2 (ja) 2012-09-19 2020-02-26 アルカームス ファーマ アイルランド リミテッド 貯蔵安定性が改善された医薬組成物
EP2900217A1 (en) * 2012-09-26 2015-08-05 Bristol-Myers Squibb Company Apixaban liquid formulations
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US20140107130A1 (en) * 2012-10-11 2014-04-17 Antrim Pharmaceuticals, LLC Oral Solution Formulations of Aripiprazole
ES2637521T3 (es) 2012-10-16 2017-10-13 Arven Ilac Sanayi Ve Ticaret A.S. Formulaciones de aripiprazol
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
JP6203682B2 (ja) * 2013-07-10 2017-09-27 共和薬品工業株式会社 アリピプラゾール含有水性液剤
CN103393594A (zh) * 2013-08-22 2013-11-20 万特制药(海南)有限公司 一种新的阿立哌唑的制剂组合物
MX2016012041A (es) 2014-03-20 2017-01-19 Alkermes Pharma Ireland Ltd Formulaciones de aripiprazol que tienen mayores velocidades de inyeccion.
WO2016189504A1 (en) * 2015-05-28 2016-12-01 Leiutis Pharmaceuticals Pvt Ltd Non-lyophilized compositions of aripiprazole and methods of preparation thereof
JP6039849B1 (ja) * 2015-06-12 2016-12-07 高田製薬株式会社 アリピプラゾール含有内用液剤
WO2017025930A1 (en) * 2015-08-12 2017-02-16 Ftf Pharma Private Limited Oral solution of aripiprazole
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations
CN108434146A (zh) * 2017-02-16 2018-08-24 天津国际生物医药联合研究院 一种hiv-1整合酶抑制剂的溶液剂及其制备方法和应用
CN109498556A (zh) * 2017-09-15 2019-03-22 万特制药(海南)有限公司 阿立哌唑口服溶液及其制备方法
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN112666267B (zh) * 2019-10-15 2023-09-26 上海上药中西制药有限公司 一种阿立哌唑药品有关物质的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU843739A3 (ru) 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
JPS54130587A (en) 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
PH17194A (en) 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS5959663A (ja) 1982-09-29 1984-04-05 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体−シクロデキストリン包接化合物
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
US5457099A (en) 1992-07-02 1995-10-10 Sawai Pharmaceutical Co., Ltd. Carbostyril derivatives and antiallergic agent
TW254855B (es) * 1993-07-28 1995-08-21 Otsuka Pharma Co Ltd
CA2285368A1 (en) * 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies Inc. Solvent system for enhanced penetration of pharmaceutical compounds
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
EP1109452A2 (en) * 1998-09-03 2001-06-27 Alcide Corporation Freeze-resistant topical germicides and methods related thereto
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US20020076437A1 (en) * 2000-04-12 2002-06-20 Sanjeev Kothari Flashmelt oral dosage formulation

Also Published As

Publication number Publication date
HK1168792A1 (en) 2013-01-11
CN1512884B (zh) 2010-05-26
YU84703A (sh) 2006-08-17
ES2377855T3 (es) 2012-04-02
CZ306181B6 (cs) 2016-09-14
EP2436384A3 (en) 2012-09-19
RS52082B (sr) 2012-06-30
EE05581B1 (et) 2012-10-15
NZ528550A (en) 2005-03-24
NO20034705L (no) 2003-11-28
UY27273A1 (es) 2002-11-29
WO2002085366A1 (en) 2002-10-31
PT1381367E (pt) 2012-03-01
EP1381367B1 (en) 2011-12-21
NO324606B1 (no) 2007-11-26
BG108216A (bg) 2004-12-30
JP2004532225A (ja) 2004-10-21
HUP0303946A3 (en) 2005-06-28
SK287948B6 (sk) 2012-06-04
DK1381367T3 (da) 2012-04-10
ATE537831T1 (de) 2012-01-15
AU2002254722B2 (en) 2006-11-09
US6977257B2 (en) 2005-12-20
EE200300523A (et) 2004-02-16
TWI337865B (en) 2011-03-01
HRP20030870B1 (en) 2011-10-31
CN1512884A (zh) 2004-07-14
UA76144C2 (uk) 2006-07-17
EP2436384B1 (en) 2015-06-10
IL158202A (en) 2008-04-13
CA2445276C (en) 2009-10-13
PL206882B1 (pl) 2010-10-29
KR20030096332A (ko) 2003-12-24
EP1381367A4 (en) 2009-07-01
RU2295960C2 (ru) 2007-03-27
HUP0303946A2 (hu) 2004-04-28
HK1058316A1 (en) 2004-05-14
CY1112606T1 (el) 2016-02-10
GEP20053602B (en) 2005-08-10
HU230456B1 (hu) 2016-07-28
CA2445276A1 (en) 2002-10-31
NO20034705D0 (no) 2003-10-21
EP1381367A1 (en) 2004-01-21
CZ20032821A3 (cs) 2004-09-15
HRP20030870A2 (en) 2004-06-30
JP4401077B2 (ja) 2010-01-20
BG66177B1 (bg) 2011-11-30
PL364666A1 (en) 2004-12-13
SK12642003A3 (sk) 2004-07-07
US20020193438A1 (en) 2002-12-19
ZA200307797B (en) 2004-10-06
EP2436384B2 (en) 2018-05-23
IS2863B (is) 2013-12-15
KR100909329B1 (ko) 2009-07-24
BR0208986A (pt) 2004-04-20
IL158202A0 (en) 2004-05-12
MY129350A (en) 2007-03-30
PE20021086A1 (es) 2002-12-14
RU2003132426A (ru) 2005-04-20
EP2436384A2 (en) 2012-04-04
AR033168A1 (es) 2003-12-03
IS6994A (is) 2003-10-14

Similar Documents

Publication Publication Date Title
MXPA03009728A (es) Solucion oral de aripiprazol.
ZA200410015B (en) Pharmaceutical salts.
GB0112834D0 (en) Medicaments
AU2002365120A8 (en) Medicaments
ZA200208561B (en) Hydraulischer druckverstarker.
ZA200308340B (en) Inhalation capsules.
DE60223075D1 (en) Aberrometer
MXPA01009037A (es) I-bet.
MXPA03005286A (es) METODO Y APARATO PARA SUPERVISAR PULSACION DE INSTALACION DE ORDEnA.
GB0128415D0 (en) Medicaments
GB0102902D0 (en) Medicaments
HK1059781A1 (en) New phenylpiperazines.
MXPA03007888A (es) Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
GB0105469D0 (en) Medicaments
EP1386919A4 (en) REMEDIES
GB0115182D0 (en) Medicaments
ZA200109508B (en) Toothbrush.
ZA200202472B (en) Toothbrush.
ZA200306611B (en) New use.
AP2001000098S (en) Marimbira.
MXPA01005709A (es) Panel-cimbra.
MXPA01005710A (es) Losa-cimbra.
GB0108590D0 (en) Medicament
GB0101470D0 (en) Medicament
SI1372624T1 (sl) Zdravilo na osnovi tramadola

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights